Ambuja Cements Limited

NSEI:AMBUJACEM Stock Report

Market Cap: ₹1.6t

Ambuja Cements Future Growth

Future criteria checks 1/6

Ambuja Cements's revenue is forecast to decline at 8.1% per annum while its annual earnings are expected to grow at 9.8% per year. EPS is expected to grow by 7.9% per annum. Return on equity is forecast to be 7.5% in 3 years.

Key information

9.8%

Earnings growth rate

7.9%

EPS growth rate

Basic Materials earnings growth8.3%
Revenue growth rate-8.1%
Future return on equity7.5%
Analyst coverage

Good

Last updated02 Aug 2024

Recent future growth updates

Recent updates

Here's Why Ambuja Cements (NSE:AMBUJACEM) Can Manage Its Debt Responsibly

Jul 23
Here's Why Ambuja Cements (NSE:AMBUJACEM) Can Manage Its Debt Responsibly

Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Have Stalled

May 30
Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Have Stalled

Ambuja Cements' (NSE:AMBUJACEM) Promising Earnings May Rest On Soft Foundations

May 09
Ambuja Cements' (NSE:AMBUJACEM) Promising Earnings May Rest On Soft Foundations

There's Reason For Concern Over Ambuja Cements Limited's (NSE:AMBUJACEM) Price

Apr 22
There's Reason For Concern Over Ambuja Cements Limited's (NSE:AMBUJACEM) Price

Ambuja Cements (NSE:AMBUJACEM) Hasn't Managed To Accelerate Its Returns

Feb 01
Ambuja Cements (NSE:AMBUJACEM) Hasn't Managed To Accelerate Its Returns

Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?

Dec 21
Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?

Ambuja Cements (NSE:AMBUJACEM) Could Be Struggling To Allocate Capital

Oct 18
Ambuja Cements (NSE:AMBUJACEM) Could Be Struggling To Allocate Capital

Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?

Sep 22
Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?

Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Paint A Concerning Picture

Jul 09
Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Paint A Concerning Picture

Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Jun 18
Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Ambuja Cements (NSE:AMBUJACEM) Will Want To Turn Around Its Return Trends

Mar 26
Ambuja Cements (NSE:AMBUJACEM) Will Want To Turn Around Its Return Trends

Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Mar 08
Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Weak Statutory Earnings May Not Tell The Whole Story For Ambuja Cements (NSE:AMBUJACEM)

Feb 15
Weak Statutory Earnings May Not Tell The Whole Story For Ambuja Cements (NSE:AMBUJACEM)

Ambuja Cements' (NSE:AMBUJACEM) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 27
Ambuja Cements' (NSE:AMBUJACEM) Shareholders Will Receive A Bigger Dividend Than Last Year

We Like These Underlying Return On Capital Trends At Ambuja Cements (NSE:AMBUJACEM)

Mar 25
We Like These Underlying Return On Capital Trends At Ambuja Cements (NSE:AMBUJACEM)

Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Mar 08
Is Ambuja Cements (NSE:AMBUJACEM) Using Too Much Debt?

Ambuja Cements' (NSE:AMBUJACEM) Dividend Will Be Increased To ₹6.30

Feb 23
Ambuja Cements' (NSE:AMBUJACEM) Dividend Will Be Increased To ₹6.30

Earnings and Revenue Growth Forecasts

NSEI:AMBUJACEM - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027266,86742,190N/AN/A6
3/31/2026230,66033,7365,205N/A11
3/31/2025196,12426,0133,180N/A12
6/30/2024327,58233,175N/AN/AN/A
3/31/2024331,59635,76811,63456,458N/A
12/31/2023322,31631,666N/AN/AN/A
9/30/2023320,09627,779-11,83426,037N/A
6/30/2023317,17020,781N/AN/AN/A
3/31/2023310,37019,245-27,9755,879N/A
12/31/2022309,82819,385-53,902-8,362N/A
9/30/2022307,01417,947N/AN/AN/A
6/30/2022302,05323,6736,76237,393N/A
3/31/2022291,50724,920N/AN/AN/A
12/31/2021289,65527,80429,75153,092N/A
9/30/2021287,93132,220N/AN/AN/A
6/30/2021283,15431,78027,03747,608N/A
3/31/2021259,81327,584N/AN/AN/A
12/31/2020245,16223,65430,98748,323N/A
9/30/2020241,84822,247N/AN/AN/A
6/30/2020240,92619,88036,90153,654N/A
3/31/2020265,22521,538N/AN/AN/A
12/31/2019271,03620,95030,71347,387N/A
9/30/2019267,05824,778N/AN/AN/A
6/30/2019266,45823,80418,21330,722N/A
3/31/2019264,12122,830N/AN/AN/A
12/31/2018260,40921,7745,95417,034N/A
9/30/2018254,51816,121N/AN/AN/A
6/30/2018248,20015,850N/AN/AN/A
3/31/2018243,47816,147N/AN/AN/A
12/31/2017235,85515,164N/A34,162N/A
9/30/2017224,32413,481N/AN/AN/A
6/30/2017215,14712,769N/AN/AN/A
3/31/2017206,20712,409N/AN/AN/A
12/31/2016201,31911,051N/A28,103N/A
9/30/2016177,44210,265N/AN/AN/A
12/31/201594,3308,079N/A15,566N/A
12/31/201499,60614,865N/A16,755N/A
12/31/201391,33912,786N/A12,675N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMBUJACEM's forecast earnings growth (9.8% per year) is above the savings rate (6.7%).

Earnings vs Market: AMBUJACEM's earnings (9.8% per year) are forecast to grow slower than the Indian market (16.9% per year).

High Growth Earnings: AMBUJACEM's earnings are forecast to grow, but not significantly.

Revenue vs Market: AMBUJACEM's revenue is expected to decline over the next 3 years (-8.1% per year).

High Growth Revenue: AMBUJACEM's revenue is forecast to decline over the next 3 years (-8.1% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AMBUJACEM's Return on Equity is forecast to be low in 3 years time (7.5%).


Discover growth companies